March 28, 2023 by Jason Wertheimer Fierce Biotech Sonoma takes ‘a big bite’ with $120M Regeneron Treg collab, tacking on up to 5 new targets Learn More
March 28, 2023 by Jason Wertheimer GeekWire Sonoma Bio inks $75M deal with Regeneron to advance cell therapies against autoimmunity Learn More
March 28, 2023 by Jason Wertheimer Endpoints News Jeffrey Bluestone brings his startup haul to $400M+, joining forces with Regeneron on cell therapies Learn More
August 24, 2022 by Jason Wertheimer Endpoints News Sonoma Bio to cement its roots in Seattle with a new waterfront manufacturing and R&D site Learn More
January 26, 2022 by Jason Wertheimer Sonoma Bio Co-Founder and Chief Executive Officer Jeffrey Bluestone, Ph.D., Receives Top Scientific Honors Learn More
August 4, 2021 by Jason Wertheimer Endpoints News Jeff Bluestone just raised $265M to develop curative cell therapies. We asked him how Learn More